FAILURE TO FIRST-LINE DIRECT ANTIVIRAL (DAA) TREATMENT OF HCV INFECTION IN AN ITALIAN REAL-LIFE URBAN SETTING

被引：0

作者：

Di Paolo, D. ^{[1
]}

Rossi, P. ^{[1
]}

Lenci, I. ^{[1
]}

Milana, M. ^{[1
]}

Masetti, C. ^{[1
]}

Santopaolo, F. ^{[1
]}

Lionetti, R. ^{[2
]}

D'Offizi, G. ^{[2
]}

Pellicelli, A. ^{[3
]}

Fondacaro, L. ^{[3
]}

Siciliano, M. ^{[4
]}

Tortora, A. ^{[4
]}

Chiesara, F. ^{[5
]}

Moretti, A. ^{[5
]}

Ceccherini-Silberstain, F. ^{[6
]}

Cento, V. ^{[6
]}

Perno, C. F. ^{[6
]}

Angelico, M. ^{[1
]}

机构：

[1] Univ Roma Tor Vergata, Hepatol Unit, Rome, Italy

[2] Ist Nazl Malattie Infett Spallanzani, Hepatol Unit, Rome, Italy

[3] Osped S Camillo Roma, Hepatol Unit, Rome, Italy

[4] Policlin Gemelli, Hepatol Unit, Rome, Italy

[5] Osped S Filippo Neri, Hepatol Unit, Rome, Italy

[6] Univ Roma Tor Vergata, Virol Unit, Rome, Italy

来源：

JOURNAL OF HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

10.1016/S0168-8278(16)01472-0

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-132

引用

页码：S755 / S755

页数：1

共 50 条

[31] DASATINIB FIRST-LINE: UPDATE DI UNA ESPERIENZA "REAL-LIFE" ITALIANA
Breccia, M.
Annunziata, M.
Nardiello, I.
Maggi, A.
Sgherza, N.
Russo-Rossi, A.
Pregno, P.
Castagnetti, F.
Iurlo, A.
Latagliata, R.
Cedrone, M.
Di Renzo, N.
Sora, F.
Rege-Cambrin, G.
Caocci, G.
Scortechini, A. R.
Greco, G.
Franceschini, L.
Sica, S.
Bocchia, M.
Crugnola, M.
Orlandi, E.
Stagno, F.
Luciano, L.
Abruzzese, E.
Rosti, G.
Specchia, G.
Guarini, A.
Saglio, G.
Alimena, G.
HAEMATOLOGICA, 2015, 100 : 127 - 127
[32] UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)
Bar, Jair
Peled, Nir
Schokrpur, Shiruyeh
Wolner, Mirjana
Rotem, Ofer
Girard, Nicolas
Nana, Frank Aboubakar
Derijcke, Sofie
Kian, Waleed
Patel, Sandip
Gantz-Sorotsky, Hadas
Zer, Alona
Moskovitz, Mor
Metro, Giulio
Rottenberg, Yakir
Calles, Antonio
Hochmair, Maximilian
Cuppens, Kristof
Decoster, Lynn
Reck, Martin
Limon, Dror
Rodriguez, Estelamari
Astaras, Christoforos
Bettini, Adrienne
Hafliger, Simon
Addeo, Alfredo
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (02) : 169 - 180
[33] UNcommon EGFR mutations: International Case series on efficacy of Osimertinib in Real-life practice in first-liNe setting (UNICORN)
Bar, J.
Kian, W.
Wolner, M.
Derijcke, S.
Girard, N.
Rottenberg, Y.
Dudnik, E.
Metro, G.
Hochmair, M. J.
Aboubakar, F.
Cuppens, K.
Decoster, L.
Reck, M.
Limon, D.
Calles Blanco, A.
Astaras, C.
Hafliger, S.
Peled, N.
Addeo, A.
ANNALS OF ONCOLOGY, 2021, 32 : S961 - S962
[34] Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting
Monforte, Antonella d'Arminio
Cozzi-Lepri, Alessandro
Di Biagio, Antonio
Marchetti, Giulia
Lo Caputo, Sergio
Rusconi, Stefano
Gianotti, Nicola
Mazzotta, Valentina
Mazzarello, Giovanni
Costantini, Andrea
Castagna, Antonella
Antinori, Andrea
Monforte, A. d'Arminio
Antinori, A.
Andreoni, M.
Castagna, A.
Castelli, F.
Cauda, R.
Di Perri, G.
Galli, M.
Iardino, R.
Ippolito, G.
Lazzarin, A.
Marchetti, G. C.
Rezza, G.
von Schloesser, F.
Viale, P.
Monforte, A. d'Arminio
Antinori, A.
Castagna, A.
Ceccherini-Silberstein, F.
Cozzi-Lepri, A.
Girardi, E.
Lo Caputo, S.
Mussini, C.
Puoti, M.
Perno, C. F.
Antinori, A.
Balotta, C.
Bandera, A.
Bonora, S.
Borderi, M.
Calcagno, A.
Capetti, A.
Capobianchi, M. R.
Castagna, A.
Ceccherini-Silberstein, F.
Cicalini, S.
Cingolani, A.
Cinque, P.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (05) : 1363 - 1367
[35] Liver stiffness and portal hypertension predict failure to DAA treatment in a real-life cohort of HCV-infected patients treated with recommended regimens
Masetti, C.
De Leonardis, F.
Rossi, P.
Bosa, A.
Di Paolo, D.
Milana, M.
Santopaolo, F.
Pecchioli, A.
Di Nardi, S.
Francioso, S.
Lenci, I.
Baiocchi, L.
Brega, A.
Marianelli, T.
Antenucci, F.
Angelico, M.
DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E50 - E51
[36] HCV resistance-associated substitutions following direct-acting antiviral therapy failure - Real-life data from Poland
Parczewski, Milosz
Janczewska, Ewa
Pisula, Arkadiusz
Dybowska, Dorota
Lojewski, Wladyslaw
Witor, Adam
Wawrzynowicz-Syczewska, Marta
Socha, Lukasz
Krygier, Rafal
Knysz, Brygida
Musialik, Joanna
Urbanska, Anna
Scheibe, Kaja
Jaroszewicz, Jerzy
INFECTION GENETICS AND EVOLUTION, 2021, 93
[37] Effectiveness of Direct Antiviral Agents in People with HCV-Monoinfection Compared to HCV/HIV Coinfection in a Real Life Setting
Lopez, Cristina Guadalupe Roman
Gonzalez, Salma Triana
Diaz, Ana Luz Cano
Lopez, Dulce Daniela Flores
Marin, Jose Antonio Mata
Martinez, Jesus Enrique Gaytan
VIRUSES-BASEL, 2024, 16 (11):
[38] Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience
Dalbeni, Andrea
Villani, Rosanna
Bevilacqua, Michele
Sacco, Federica
Faccincani, Diego
Cattazzo, Filippo
Cavallone, Francesco
Mantovani, Anna
Ceruti, Vittoria
Ieluzzi, Donatella
Paon, Veronica
Mantovani, Alessandro
Serviddio, Gaetano
Sacerdoti, David
JOURNAL OF DIGESTIVE DISEASES, 2022, 23 (5-6) : 324 - 330
[39] Adalimumab as first-line anti-TNF treatment in ulcerative colitis. A "real-life" observational study
Lorente, R.
Verdejo, C.
Roncero, O.
Lopez, D.
Robledo, P.
Bouhmidi, A.
Hervias, D.
JOURNAL OF CROHNS & COLITIS, 2015, 9 : S280 - S280
[40] First-line CyborD treatment for graft ineligible multiple myeloma patients: Real-life efficacy and tolerability.
Duquette, Dominic
Germain, Marie-Michelle
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →